Panganting, Rosselle .
HRN: 25-86-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2024
CEFUROXIME 1.5GM (VIAL)
11/26/2024
11/27/2024
IV
1.5g
Q8 X 3 Doses
S/P NSVD With RMLE And Repair; PROM X 10 Hours
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes